Although further studies are needed to better understand the underlying mechanism of GH/IGF-1 contribution to the onset and course of ALS, this evidence suggests that ghrelin and its synthetic analogues could be an interesting strategy to promote the restoration of the GH/IGF-1 axis. Here, GHRL is linked to amyotrophic lateral sclerosis.